Edition:
United Kingdom

Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

7.45USD
7:12pm GMT
Change (% chg)

$0.10 (+1.36%)
Prev Close
$7.35
Open
$7.40
Day's High
$7.50
Day's Low
$7.40
Volume
1,849
Avg. Vol
5,726
52-wk High
$9.20
52-wk Low
$5.05

Latest Key Developments (Source: Significant Developments)

Chembio Diagnostics Appoints Neil Goldman As CFO
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO DIAGNOSTICS ANNOUNCES APPOINTMENT OF NEIL A. GOLDMAN AS CHIEF FINANCIAL OFFICER.CHEMBIO DIAGNOSTICS - GOLDMAN SUCCEEDS RICHARD J. LARKIN, WHO HAS SERVED AS CO'S EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER SINCE 2003.  Full Article

Chembio Diagnostics And Astrazeneca Collaborates To Develop Point-Of-Care Diagnostic Test
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - Astrazeneca Plc ::CHEMBIO DIAGNOSTICS AND ASTRAZENECA ENTER A COLLABORATION TO DEVELOP POINT-OF-CARE DIAGNOSTIC TEST.CHEMBIO DIAGNOSTICS INC - UNDER TERMS OF 18-MONTH AGREEMENT, CO WILL RECEIVE UP TO $2.9 MILLION IN FUNDING FROM ASTRAZENECA.  Full Article

Chembio Diagnostics Awarded UNICEF Contract
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO DIAGNOSTICS AWARDED UNICEF CONTRACT TO SUPPLY POINT-OF-CARE DPP® ZIKA ASSAYS AND DPP® MICRO READERS.CHEMBIO DIAGNOSTICS INC - ‍CO HAS BEEN AWARDED A CONDITIONAL LONG TERM ARRANGEMENT FROM UNICEF FOR PURCHASES OF COMPANY'S DPP ZIKA SYSTEM​.CHEMBIO DIAGNOSTICS - ‍UNICEF LTA, WHICH IS VALID THROUGH DEC 31, 2019, INCLUDES PURCHASE COMMITMENT OF $1.5 MILLION, POSSIBLE PURCHASES UP TO $3.4 MILLION.  Full Article

Chembio Diagnostics posts Q3 loss of $0.05 per share
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Chembio Diagnostics Inc :Chembio diagnostics reports third quarter 2017 financial results.Q3 loss per share $0.05.Q3 revenue rose 102 percent to $7.6 million.  Full Article

Chembio expands exclusive distribution agreements with Isla Lab to include Puerto Rico and U.S. Virgin Islands
Friday, 23 Sep 2016 

Chembio Diagnostics Inc : Chembio expands exclusive distribution agreements with Isla Lab to include Puerto Rico and U.S. Virgin Islands . Isla Lab becomes Chembio's exclusive distribution partner throughout Caribbean region, including Puerto Rico and U.S. Virgin Islands .Entered into an exclusive distribution agreement with Isla Lab LLC that includes both Puerto Rico and U.S. Virgin Islands.  Full Article

Chembio enters into exclusive agreement with Isla Lab
Thursday, 18 Aug 2016 

Chembio Diagnostics : Chembio expands product distribution through exclusive agreement with Isla Lab in the Caribbean . Entered into agreement with Isla Lab Caribbean, which covers twenty-five nations in Caribbean, excluding Puerto Rico, U.S. Virgin Islands .Agreement with Isla Lab Caribbean initially includes co's products, which have met regulatory requirements to be sold in Caribbean region.  Full Article

Chembio Diagnostics Q2 loss per share $0.86
Thursday, 11 Aug 2016 

Chembio Diagnostics Inc : Q2 loss per share $0.86 .Q2 revenue fell 51.4 percent to $3.27 million.  Full Article

Chembio's Zika test cleared for sale in Europe and Caribbean
Wednesday, 27 Jul 2016 

Chembio Diagnostics Inc :Chembio's DPP Zika IgM/IgG assay obtains CE mark for rapid point-of-care detection of Zika virus.  Full Article

Chembio Diagnostics says proposed public offering of shares
Monday, 25 Jul 2016 

Chembio Diagnostics Inc : Chembio Diagnostics announces proposed public offering of common shares .Has commenced an underwritten public offering of $10.0 million of common shares.  Full Article

Chembio Diagnostics posts Q1 loss per share of $0.03
Thursday, 12 May 2016 

Chembio Diagnostics Inc : Chembio Diagnostics reports first quarter 2016 financial results . Q1 loss per share $0.03 .Q1 revenue rose 5.9 percent to $6.6 million.  Full Article